Death rates and disability in newborn PAH have declined globally since 1990, but inequalities remain, according to a 30-year ...

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Worldwide, pulmonary arterial hypertension affects more than 2 of every 100,000 women and girls of childbearing age, a new ...

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...

[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a rare, life-threatening disease characterized by high blood pressure in the lungs due to damage to the pulmonary arteries. These ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary hypertension is a rare lung disease characterized by increased blood pressure in the pulmonary arteries that eventually makes breathing very difficult. Breathing is the most important thing ...